Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway

Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant‐based compound, mimosine, in MCF‐7 cells by in silico model. Cell...

Full description

Bibliographic Details
Main Authors: Huq, AKM Moyeenul, Wai, Lam Kok, Rullah, Kamal, Mohd Aluwi, Mohd Fadhlizil Fasihi, Stanslas, Johnson, Jamal, Jamia Azdina
Format: Article
Language:English
English
Published: Wiley Online Library 2019
Subjects:
Online Access:http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/1/Kamal%20Rullah%2018.pdf
http://irep.iium.edu.my/74950/3/2019-Chemical_Biology_%26_Drug_Design.pdf
id iium-74950
recordtype eprints
spelling iium-749502019-11-07T08:20:49Z http://irep.iium.edu.my/74950/ Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway Huq, AKM Moyeenul Wai, Lam Kok Rullah, Kamal Mohd Aluwi, Mohd Fadhlizil Fasihi Stanslas, Johnson Jamal, Jamia Azdina RM Therapeutics. Pharmacology RS403 Materia Medica-Pharmaceutical Chemistry Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant‐based compound, mimosine, in MCF‐7 cells by in silico model. Cell viability and proliferation, ERα‐SRC1 coactivator activity and expression of specific ERα‐dependent marker TFF1 and PGR genes were evaluated. Binding modes of 17β‐oestradiol and mimosine at the ERα ligand binding domain were compared using docking and molecular dynamics simulation experiments followed by binding interaction free energy calculation with molecular mechanics/Poisson–Boltzmann surface area. Mimosine showed increased cellular viability (64,450 cells/ml) at 0.1 μM with significant cell proliferation (120.5%) compared to 17β‐oestradiol (135.2%). ER antagonist tamoxifen significantly reduced proliferative activity mediated by mimosine (49.9%). Mimosine at 1 μM showed the highest ERα binding activity through increased SRC1 recruitment at 186.9%. It expressed TFF1 (11.1‐fold at 0.1 μM) and PGR (13.9‐fold at 0.01 μM) genes. ERα‐mimosine binding energy was −49.9 kJ/mol, and it interacted with Thr347, Gly521 and His524 of ERα‐LBD. The results suggested that mimosine has oestrogenic activity. Wiley Online Library 2019-03 Article PeerReviewed application/pdf en http://irep.iium.edu.my/74950/1/Kamal%20Rullah%2018.pdf application/pdf en http://irep.iium.edu.my/74950/3/2019-Chemical_Biology_%26_Drug_Design.pdf Huq, AKM Moyeenul and Wai, Lam Kok and Rullah, Kamal and Mohd Aluwi, Mohd Fadhlizil Fasihi and Stanslas, Johnson and Jamal, Jamia Azdina (2019) Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway. Chemical Biology and Drug Design, 93 (3). pp. 1-10. ISSN 1747-0285 (In Press) https://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13404 10.1111/cbdd.13404
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
topic RM Therapeutics. Pharmacology
RS403 Materia Medica-Pharmaceutical Chemistry
spellingShingle RM Therapeutics. Pharmacology
RS403 Materia Medica-Pharmaceutical Chemistry
Huq, AKM Moyeenul
Wai, Lam Kok
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
description Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant‐based compound, mimosine, in MCF‐7 cells by in silico model. Cell viability and proliferation, ERα‐SRC1 coactivator activity and expression of specific ERα‐dependent marker TFF1 and PGR genes were evaluated. Binding modes of 17β‐oestradiol and mimosine at the ERα ligand binding domain were compared using docking and molecular dynamics simulation experiments followed by binding interaction free energy calculation with molecular mechanics/Poisson–Boltzmann surface area. Mimosine showed increased cellular viability (64,450 cells/ml) at 0.1 μM with significant cell proliferation (120.5%) compared to 17β‐oestradiol (135.2%). ER antagonist tamoxifen significantly reduced proliferative activity mediated by mimosine (49.9%). Mimosine at 1 μM showed the highest ERα binding activity through increased SRC1 recruitment at 186.9%. It expressed TFF1 (11.1‐fold at 0.1 μM) and PGR (13.9‐fold at 0.01 μM) genes. ERα‐mimosine binding energy was −49.9 kJ/mol, and it interacted with Thr347, Gly521 and His524 of ERα‐LBD. The results suggested that mimosine has oestrogenic activity.
format Article
author Huq, AKM Moyeenul
Wai, Lam Kok
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
author_facet Huq, AKM Moyeenul
Wai, Lam Kok
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
author_sort Huq, AKM Moyeenul
title Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
title_short Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
title_full Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
title_fullStr Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
title_full_unstemmed Oestrogenic activity of mimosine on MCF‐7 breast cancer cell line through the ERα‐mediated pathway
title_sort oestrogenic activity of mimosine on mcf‐7 breast cancer cell line through the erα‐mediated pathway
publisher Wiley Online Library
publishDate 2019
url http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/
http://irep.iium.edu.my/74950/1/Kamal%20Rullah%2018.pdf
http://irep.iium.edu.my/74950/3/2019-Chemical_Biology_%26_Drug_Design.pdf
first_indexed 2023-09-18T21:46:04Z
last_indexed 2023-09-18T21:46:04Z
_version_ 1777413458056183808